AEterna Zentaris Inc (AEZS.O)
30 Sep 2016
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|65||2014||Chairman of the Board, President, Chief Executive Officer|
|2007||Chief Financial Officer, Senior Vice President|
|62||2014||Senior Vice President, Chief Administrative Officer, General Counsel|
|2014||Senior Vice President, Chief Scientific Officer, Chief Medical Officer|
|2013||Chief Commercial Officer, Senior Vice President|
- BRIEF-AEterna Zentaris announces expiration of remaining Series B warrants
- BRIEF-Aeterna Zentaris reports Q2 loss per share $0.71
- BRIEF-Aeterna and Rafa Laboratories sign license agreement for Zoptrex in Israel
- BRIEF-Aeterna Zentaris, Orient Europharma sign license agreement for Zoptrex
- BRIEF-Aeterna zentaris to file a NDA for zoptrex in first half of 2017